Literature DB >> 9551747

Partitioning of the elastic work of inspiration in patients with COPD during exercise.

P Sliwinski1, D Kaminski, J Zielinski, S Yan.   

Abstract

During exercise, dynamic hyperinflation-induced intrinsic positive end-expiratory pressure (PEEPi) and decreased dynamic lung compliance (CL,dyn) of patients with chronic obstructive pulmonary disease (COPD) increase the elastic work of inspiration (Wi) more than would be predicted from the increase in tidal volume (VT). This contributes significantly to their exertional breathlessness. In 10 stable patients with COPD, the dynamic Wi was measured during incremental bicycle exercise to exhaustion. The total Wi was then partitioned into the portion required to overcome PEEPi (Wi,PEEPi) and nonPEEPi elastic load (Wi,nonPEEPi). The latter is used to overcome the increase in the total respiratory system elastance during inflation. From resting breathing to peak exercise, Wi more than doubled (p<0.001). This increase was largely due to Wi,PEEPi, which significantly rose from 1.7+/-0.3 to 5.3+/-0.8 L x cm H2O(-1) (p<0.001). In comparison, Wi,nonPEEPi increased from only 3.0+/-0.4 to 5.1+/-0.5 L x cm H2O(-1) (p<0.01). Consequently, Wi,PEEPi as a fraction of total Wi increased from 35.5+/-5.6 to 51.0+/-3.3% (p<0.02). In addition, the measured Wi,nonPEEPi at peak exercise, when expressed as a percentage of its value during resting breathing, was 25% more than that predicted from the increase in VT alone. Assuming a constant chest wall compliance, this can be attributed to the exercise-induced decrease in CL,dyn, which was 0.27+/-0.04 and 0.17+/-0.02 L x cm H2O(-1) (p<0.01), respectively, during resting breathing and peak exercise. In conclusion, the dynamic hyperinflation-induced intrinsic positive end-expiratory pressure is more important than the increase in tidal volume in raising the work of inspiration during exercise in patients with chronic obstructive pulmonary disease; the decrease in dynamic lung compliance plays a definite but less important role.

Entities:  

Mesh:

Year:  1998        PMID: 9551747     DOI: 10.1183/09031936.98.11020416

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

2.  The Effect of Breathing Retraining Using Metronome-Based Acoustic Feedback on Exercise Endurance in COPD: A Randomized Trial.

Authors:  Eileen G Collins; Christine Jelinek; Susan O'Connell; Jolene Butler; Domenic Reda; Franco Laghi
Journal:  Lung       Date:  2019-02-09       Impact factor: 2.584

Review 3.  The impact of exercise training intensity on change in physiological function in patients with chronic obstructive pulmonary disease.

Authors:  Scott J Butcher; Richard L Jones
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

4.  Effect of expiratory loaded breathing during moderate exercise on intercostal muscle oxygenation.

Authors:  Quentin Bretonneau; Aurélien Pichon; Claire de Bisschop
Journal:  Multidiscip Respir Med       Date:  2020-10-26

Review 5.  Pulmonary characteristics in COPD and mechanisms of increased work of breathing.

Authors:  Stephen H Loring; Mauricio Garcia-Jacques; Atul Malhotra
Journal:  J Appl Physiol (1985)       Date:  2009-04-09

6.  Work of breathing during arm bracing in normal male subjects.

Authors:  Tomoyuki Ogino; Kyoshi Mase; Shigefumi Murakami; Kazuhisa Domen
Journal:  Can J Respir Ther       Date:  2020-11-26

7.  Induction of dynamic hyperinflation by expiratory resistance breathing in healthy subjects - an efficacy and safety study.

Authors:  Matthias Helmut Urban; Anna Katharina Mayr; Ingrid Schmidt; Eduard Margulies; Erwin Grasmuk-Siegl; Otto Chris Burghuber; Georg-Christian Funk
Journal:  Exp Physiol       Date:  2020-11-23       Impact factor: 2.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.